Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations
Tricia M. McKeever(University of Nottingham), Timothy Harrison(Nottingham Biomedical Research Centre), Eleanor Mitchell(University of Nottingham), Graham Devereux(Nottingham Biomedical Research Centre), Christopher E. Brightling(NIHR Leicester Biomedical Research Centre), Andrew Wilson(University of Leicester), David Price(Optimum Therapeutics (United States)), Lelia Duley(National Milk Records (United Kingdom)), Lucy Bradshaw(University of Nottingham), Mike Thomas(University of Southampton), Samantha Walker(Asthma UK), Ian Pavord(Oxford BioMedica (United Kingdom)), Rebecca Haydock(Nottingham Biomedical Research Centre), Andrew Skeggs(University Hospitals of Derby and Burton NHS Foundation Trust), Bernard Higgins(Newcastle upon Tyne Hospital), Kevin Mortimer(University of Nottingham)
Cited by 149
Related Papers
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks
|Nature Genetics|2017|591
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
|The Lancet Respiratory Medicine|2015|584
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
|Cochrane Database of Systematic Reviews|2010|581
Health status of UK care home residents: a cohort study
|Age and Ageing|2013|421